Milestone scientific projects revenue to increase over 85% to more than $10 million for 2021

Roseland, n.j., jan. 10, 2022 (globe newswire) -- milestone scientific inc. (nyse:mlss), a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, today provided revenue guidance for the fourth quarter and year ended december 31, 2021. the company anticipates revenue of over $2.6 million for the fourth quarter of 2021 compared to $2.2 million for the fourth quarter of 2020 and revenue in excess of $10 million for the fiscal year 2021 compared to revenue of $5.4 million for fiscal 2020.
MLSS Ratings Summary
MLSS Quant Ranking